JOHANNA SCHUESSLER: Open Payments
NPI 1871612309 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 29 payments from 13 companies in 2025. Trend: 2023 $279 · 2024 $464 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $159 |
| PFIZER INC. | 3 | $48 |
| Edwards Lifesciences Corporation | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $24 |
| Radius Health, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
Products named: VRAYLAR, QULIPTA, TRELEGY ELLIPTA, GEMTESA, UBRELVY, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Veozah, Tymlos.
Industry payments across MO — which companies pay providers there.
